Incyte blood cancer drug combo reduces disease-progression risk but with high side-effect rate

Investing.com Gold reports: Incyte blood cancer drug combo reduces disease-progression risk but with high side-effect rate. Full body text was unavailable at ingest time, so this brief is based on headline context.